Australia markets close in 42 minutes

Enzymatica AB (EN9.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.2580+0.0100 (+4.03%)
At close: 09:43PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
47,288
50,904
48,948
57,243
111,245
Cost of revenue
16,907
19,041
20,494
23,891
35,286
Gross profit
30,381
31,863
28,454
33,352
75,959
Operating expenses
Research development
16,244
15,310
26,497
24,212
22,486
Selling general and administrative
69,743
67,785
71,500
55,423
66,521
Total operating expenses
82,471
79,925
96,672
78,599
88,021
Operating income or loss
-52,090
-48,062
-68,218
-45,247
-12,062
Interest expense
2,432
2,089
997
889
804
Income before tax
-54,150
-49,720
-68,747
-45,700
-13,062
Income tax expense
-478
9
-89
-307
159
Income from continuing operations
-53,672
-49,729
-68,658
-45,393
-13,221
Net income
-53,671
-49,728
-68,657
-45,393
-13,221
Net income available to common shareholders
-53,671
-49,728
-68,657
-45,393
-13,221
Basic EPS
-0.35
-0.30
-0.44
-0.31
-0.09
Diluted EPS
-0.35
-0.30
-0.44
-0.31
-0.09
Basic average shares
164,257
164,257
154,302
146,625
142,876
Diluted average shares
164,257
164,257
154,302
146,625
142,876